← Open Payments lookup

MAKEDA BERHANE: Open Payments

NPI 1730834722 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,603 in 35 payments from 13 companies in 2025. Trend: 2023 $813 · 2024 $899 · 2025 $1,603

Food & beverage: $1,519Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.4$339
ABBVIE INC.7$283
Madrigal Pharmaceuticals4$224
Regeneron Healthcare Solutions, Inc.7$212
Ardelyx, Inc.1$122
Intercept Pharmaceuticals, Inc.1$111
PFIZER INC.1$102
QOL Medical, LLC3$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$53
Exact Sciences Corporation2$42

Products named: TREMFYA, REZDIFFRA, LINZESS, DUPIXENT, IBSRELA, OCALIVA, VELSIPITY, Sucraid.

Industry payments across MD — which companies pay providers there.